Patel Amit K, Rogers Craig G, Johnson Anna, Noyes Sabrina L, Qi Ji, Miller David, Shervish Edward, Stockton Benjamin, Lane Brian R
Henry Ford Health System, Detroit, MI, USA.
Department of Urology, Michigan Medicine, Ann Arbor, MI, USA.
Eur Urol Open Sci. 2020 Dec 4;23:13-19. doi: 10.1016/j.euros.2020.11.002. eCollection 2021 Jan.
While surgical excision remains the principal management strategy for clinical T1 renal masses (cT1RMs), the rates of noninterventional approaches are not well known. Most single-institution and population-based series suggest rates below 10%.
To evaluate the use of observation for newly diagnosed cT1RM patients in academic and community-based practices across a statewide collaborative.
The Michigan Urological Surgery Improvement Collaborative-Kidney mass: Identifying and Defining Necessary Evaluation and therapY (MUSIC-KIDNEY) commenced data collection in September 2017 by recording clinical, radiographic, pathologic, and short-term follow-up data for cT1RM patients at 13 diverse practices. Patients with complete data were assessed at >90 d after initial evaluation as to whether observation or treatment was performed.
Relationships with outcomes were analyzed using multivariable logistic regression, chi-square test, and Wilcoxon rank-sum test.
Out of 965 patients, observation was employed in 48% ( = 459), with practice-level rates ranging from 0% to 68%. Patients managed with observation (vs treatment) were significantly older (71.2 vs 62.8 yr, < 0.0001) and had smaller tumors (2.3 vs 3.4 cm, < 0.0001). Observation was used for 53.5% of cT1a renal masses, for 29.9% of cT1b renal masses, and for 42.5%, 53.7%, and 63.9% of radiographically solid, Bosniak III-IV cystic, and indeterminate cT1RMs, respectively. Factors significantly associated with observation in multivariable analysis included lesion type (Bosniak III-IV vs solid, = 0.017), tumor stage (cT1a vs cT1b, < 0.001), and higher age ( < 0.001). A short duration of follow-up limits the assessment of longer-term patient management.
Noninterventional management of cT1RMs is common across the MUSIC-KIDNEY collaborative, with wide variability across practices. Factors associated with observation were advanced age, smaller tumor size, and cystic tumor type. Durability of the initial decision for observation (delayed intervention vs active surveillance vs less active surveillance) will be a focus of subsequent study.
The Michigan Urological Surgery Improvement Collaborative: Kidney mass: Identifying and Defining Necessary Evaluation and therapY (MUSIC-KIDNEY) quality improvement collaborative assessed the current utilization of initial observation of a renal mass ≤7 cm across a diverse group of urology practices and found it to be used in 48% of patients. We found that the factors predicting observation were advanced age, smaller tumor size, and cystic tumor type.
虽然手术切除仍然是临床T1期肾肿块(cT1RMs)的主要治疗策略,但非介入性治疗方法的使用率尚不清楚。大多数单机构和基于人群的系列研究表明,其使用率低于10%。
评估在全州范围内的学术和社区医疗机构中,对新诊断的cT1RM患者采用观察等待治疗的情况。
设计、地点和参与者:密歇根泌尿外科手术改进协作组-肾肿块:识别和定义必要的评估与治疗(MUSIC-KIDNEY)于2017年9月开始收集数据,记录了13个不同医疗机构中cT1RM患者的临床、影像学、病理和短期随访数据。对有完整数据的患者在初次评估后>90天进行评估,以确定是否进行了观察等待或治疗。
使用多变量逻辑回归、卡方检验和Wilcoxon秩和检验分析与结局的关系。
在965例患者中,48%(n = 459)采用了观察等待治疗,各医疗机构的使用率从0%到68%不等。采用观察等待治疗(与接受治疗相比)的患者年龄显著更大(71.2岁对62.8岁,P < 0.0001),且肿瘤更小(2.3 cm对3.4 cm,P < 0.0001)。53.5%的cT1a期肾肿块、29.9%的cT1b期肾肿块以及分别42.5%、53.7%和63.9%的影像学表现为实性、Bosniak III-IV级囊性和不确定的cT1RMs采用了观察等待治疗。多变量分析中与观察等待治疗显著相关的因素包括病变类型(Bosniak III-IV级囊性对实性,P = 0.017)、肿瘤分期(cT1a对cT1b,P < 0.001)以及年龄较大(P < 0.001)。随访时间较短限制了对患者长期管理的评估。
在MUSIC-KIDNEY协作组中,cT1RMs的非介入性管理很常见,各医疗机构之间存在很大差异。与观察等待治疗相关的因素包括年龄较大、肿瘤较小以及囊性肿瘤类型。观察等待治疗初始决策的持久性(延迟干预与主动监测与不太积极的监测)将是后续研究的重点。
密歇根泌尿外科手术改进协作组:肾肿块:识别和定义必要的评估与治疗(MUSIC-KIDNEY)质量改进协作组评估了不同泌尿外科医疗机构中对≤7 cm肾肿块进行初始观察等待治疗的当前使用率,发现48%的患者采用了该方法。我们发现预测观察等待治疗的因素是年龄较大、肿瘤较小以及囊性肿瘤类型。